Public Biobanks: Calculation and Recovery of Costs
暂无分享,去创建一个
Gabriele Anton | Georges Dagher | Paul Hofman | Bruno Clément | Barbara Parodi | Martin Yuille | Kurt Zaltoukal | Heinz-Erich Wichmann | Lukasz Kozera | Christian Bréchot | H. Wichmann | Georges Dagher | M. Yuille | G. Anton | B. Parodi | P. Hofman | C. Bréchot | Lukasz Kozera | Bruno Clément | Kurt Zaltoukal
[1] Jennifer R. Harris,et al. A P3G Generic Access Agreement for Population Genomic Studies , 2013, Nature Biotechnology.
[2] M. Waldenberger,et al. Comprehensive catalog of European biobanks , 2011, Nature Biotechnology.
[3] Biobanks need pharma , 2009, Nature.
[4] Kurt Zatloukal,et al. Public–private relationships in biobanking: a still underestimated key component of open innovation , 2013, Virchows Archiv.
[5] Jan-Eric Litton,et al. Biobanking for Europe , 2007, Briefings Bioinform..
[6] C. Compton,et al. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. , 2011, Journal of the National Cancer Institute. Monographs.
[7] B. Knoppers,et al. Intellectual property rights in publicly funded biobanks: much ado about nothing? , 2011, Nature Biotechnology.